Study record

MOTS-c: an equal opportunity insulin sensitizer

Kim SJ, Miller B, Kumagai H et al. · J Mol Med (Berl) · 2019

ReviewEvidence tier R
PubMed 30788534doi:10.1007/s00109-019-01758-0Full text (PMC)Compare with another study

What this study reported

No abstract is available; the title describes MOTS-c as an insulin sensitizer. Content and any data cannot be determined from the record.

Limitations

Title-only record; design and content cannot be assessed.

Study record

Annotated fields for this study
Study modelReview
Substance studiedNot reported
SpeciesNot reported
System studiedLetter on MOTS-c as an insulin sensitizer (no abstract available)
PopulationNot reported
DesignLetter
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measurednot reported
Pathways measuredInsulin & glucose handling
Research areasMetabolic
Evidence tierR — Review (context, not evidence)
Publication typesLetter, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
n/a
Sample size
Not reported
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
n/a

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the title only, because no abstract is indexed.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.